Actively Recruiting

Phase 4
Age: 6Months - 6Months
All Genders
Healthy Volunteers
NCT05758532

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Led by Laure Pittet, MD-PhD · Updated on 2024-05-29

500

Participants Needed

1

Research Sites

193 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate the off-target/non-specific effects of the measles-mumps-rubella (MMR) vaccine in children.

CONDITIONS

Official Title

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Who Can Participate

Age: 6Months - 6Months
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent
  • Child is 6 months old
  • Child is in overall good health without significant diseases such as kidney failure, liver dysfunction, or heart disease
  • Child is fully immunised for age according to the Swiss vaccination schedule, including at least 2 doses of DTP-containing vaccine
  • The last vaccine dose was received at least 2 weeks before enrollment
Not Eligible

You will not qualify if you...

  • Immunosuppression or suspected immunosuppression
  • Allergy to any component of the MMR vaccine
  • Receipt of a live-attenuated vaccine within 4 weeks before enrollment
  • Refusal of vaccination
  • Indication for early MMR vaccination due to measles outbreak, planned immunosuppression, or travel to high-risk areas
  • Need for MMR-varicella vaccination instead of MMR, including severe eczema or parental request
  • Inability of parent or guardian to follow study procedures due to language, psychological, compliance, or substance abuse issues
  • Planned move out of country or prolonged absence during the trial
  • More than one sibling in the trial (only one child from multiple pregnancy can enroll)
  • Temporary contraindication to MMR such as active illness at the time of enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospitals of Geneva

Geneva, Switzerland, 1211

Actively Recruiting

Loading map...

Research Team

L

Laure F Pittet, MD-PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

PREVENTION

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children | DecenTrialz